Astra-Idl Pharma Private Limited

Pharmaceutical trading company established in 2019, based in Raipur, Chattisgarh.

2019 | Raipur, Chattisgarh (India) | Active
Last Updated: October 23, 2024

Astra-Idl Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 6 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth -90.06%
  • Profit Growth 100.48%
  • Ebitda 115.32%
  • Net Worth 0.12%
  • Total Assets -42.97%

About Astra-Idl Pharma

Astra-Idl Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 July 2019 (Five years and six months 14 days old ). Its registered office is in Raipur, Chattisgarh, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Ritesh Agrawal and Sarthak Agrawal serve as directors at the Company.

Company Details

  • Location

    Raipur, Chattisgarh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24304CT2019PTC009418

  • Company No.

    009418

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    22 Jul 2019

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chhattisgarh

Industry

Pharma

Who are the key members and board of directors at Astra-Idl Pharma?

Board Members (2)

Name Designation Appointment Date Status
Ritesh Agrawal Country flag representing In Additional Director 08-Aug-2024 Current
Sarthak Agrawal Country flag representing In Director 03-Jun-2023 Current

Financial Performance of Astra-Idl Pharma.

Astra-Idl Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 90.06% decrease. The company also saw a substantial improvement in profitability, with a 100.48% increase in profit. The company's net worth moved up by a moderate rise of 0.12%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
-90.06%
Revenue from Operations
-90.38%
Total Assets
-42.97%
Profit or Loss
100.48%
Net Worth
0.12%
EBITDA
115.32%

What is the Ownership and Shareholding Structure of Astra-Idl Pharma?

In 2023, Astra-Idl Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Astra-Idl Pharma?

Unlock and access historical data on people associated with Astra-Idl Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Astra-Idl Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astra-Idl Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Astra-Idl Pharma

Recent activity within the organization

  • Director Appointment

    Ritesh Agrawal was appointed as a Additional Director was appointed as a Additional Director on 08 Aug 2024 & has been associated with this company since 5 months 26 days .

    08 Aug 2024

  • Annual General Meeting

    Astra-Idl Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Director Appointment

    Sarthak Agrawal was appointed as a Director was appointed as a Director on 03 Jun 2023 & has been associated with this company since 1 year 8 months .

    03 Jun 2023

  • Balance Sheet

    Astra-Idl Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chhattisgarh.

    31 Mar 2023

  • Company Incorporation

    Astra-Idl Pharma Private Limited was registered on 22 Jul 2019 with Roc Chhattisgarh & aged 5 years 6 months as per MCA records.

    22 Jul 2019

Frequently asked questions

  • Astra-Idl Pharma Private Limited was incorporated on 22 Jul 2019.

  • The authorized share capital of Astra-Idl Pharma Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Astra-Idl Pharma Private Limited.

    • Ritesh Agrawal
    • Sarthak Agrawal
  • As per Ministry of Corporate Affairs (Mca), the registered address of Astra-Idl Pharma Private Limited is Qt.No.8 Priyadarshini Nagar Near Balaji Distributor Ring Road India, Raipur, Chattisgarh, 492001.

  • The corporate identification number (CIN) of Astra-Idl Pharma Private Limited is U24304CT2019PTC009418 and the company number is 009418 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Astra-Idl Pharma Private Limited has fallen by -90.06%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Astra-Idl Pharma Private Limited has experienced an upsurge of 0.12%.

  • The most recent Balance Sheet for Astra-Idl Pharma Private Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Pharmaceutical Retailers & Distributors